skip navigation links
National Cancer Institute
EVS Logo NCI Term Browser Enterprise Vocabulary Services
Terminologies Value Sets Mappings
Version: 17.08d (Release date: 2017-08-28)
SearchBox Top
SearchBox Bottom
Quizartinib (Code C68936)

Terms & Properties Synonym Details Relationships Mapping View All  
Terms & Properties

Preferred Name: Quizartinib

Definition: An orally available small molecule with potential antineoplastic activity. Quizartinib selectively inhibits class III receptor tyrosine kinases, including FMS-related tyrosine kinase 3 (FLT3/STK1), colony-stimulating factor 1 receptor (CSF1R/FMS), stem cell factor receptor (SCFR/KIT), and platelet derived growth factor receptors (PDGFRs), resulting in inhibition of ligand-independent leukemic cell proliferation and apoptosis. Mutations in FLT3, resulting in constitutive activation, are the most frequent genetic alterations in acute myeloid leukemia (AML) and occur in approximately one-third of AML cases.

Display Name: Quizartinib

Label: Quizartinib

NCI Thesaurus Code: C68936 (Search for linked caDSR metadata)  (search value sets)

NCI Metathesaurus Link: C2980091  (see NCI Metathesaurus info)

Synonyms & Abbreviations: (see Synonym Details)
N-(5-tert-butyl-isoxazol-3-yl)-N'-{4-[7-(2-morpholin-4-yl-ethoxy)imidazo [2,1-b] [1,3] benzothiazol 2-yl]phenyl}urea

External Source Codes: 
CAS Registry Number 950769-58-1 (see NLM ChemIDplus info)
PDQ Closed Trial Search ID 547019
PDQ Open Trial Search ID 547019 (check for NCI PDQ open clinical trial info)
UMLS CUI C2980091

Other Properties:
     Name Value (qualifiers indented underneath)
Chemical_Formula C29H32N6O4S
code C68936
Contributing_Source CTRP
Contributing_Source FDA
Legacy_Concept_Name FLT-3_Kinase_Inhibitor_AC220
Semantic_Type Pharmacologic Substance

Additional Concept Data: 
Defined Fully by Roles: No  


Mainbox Bottom